GT Biopharma GTBP
NASDAQ GTBP
$5.46 -0.06 (-1.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Gains from Investment Securities (2010 - 2024)

Updated

Analysis

GT Biopharma (GTBP) Gains from Investment Securities (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 GT Biopharma 7.68 Mn -15.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 -2,000.00
Dec 31, 2023 5,000.00
Mar 31, 2023 29,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 58,000.00
Jun 30, 2022 -6,000.00
Mar 31, 2022 -24,000.00
Dec 31, 2021 168,000.00
Sep 30, 2021 502,000.00
Jun 30, 2021 -480,000.00
Mar 31, 2021 21,000.00
Sep 30, 2011 681,000.00
Jun 30, 2011 -1,000.00
Sep 30, 2010 44,000.00
Jun 30, 2010 773,000.00
API Access

GT Biopharma Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=GTBP&period=max&api_key=YOUR_API_KEY